The global insulin pump market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period (2022-2028). The development of advanced pumps powered by smart technologies, such as artificial intelligence (AI) and machine learning (ML) by some key medical device manufacturers is exponentially promoting the demand for the insulin pumps across the globe. Smart technologies including AI and ML has rapidly penetrated into the healthcare IT and are now steadily heading towards diabetes management. These innovations in insulin pumps are resulting in more efficient and convenient pumps with greater patient satisfaction. 

The global fertility drugs market is anticipated to grow at a substantial CAGR of around 5.1% during the forecast period (2022-2028). The increasing average age of conceiving, changing lifestyle and cultural shifts, rising prevalence of polycystic ovarian syndrome among the younger women, and government policies and schemes for infertility treatment are factors that drive the growth of the global fertility drug market. For instance, according to Kaiser Family Foundation, the US government has supported family planning and reproductive health by funding $608 million including funding for United Nations Population Fund (UNFPA) in 2020, which is up from $425 million in 2006. 

The global oropharyngeal cancer diagnosis and therapeutics market are anticipated to grow at a considerable CAGR of 4.5% during the forecast period. The launch prices of new cancer drugs in the market have substantially increased in recent years despite growing concerns about the quantity and quality of evidence supporting their approval by the US Food and Drug Administration (FDA). For instance, in March 2022, the FDA approved Novartis’ Pluvicto, previously known as 177Lu-PSMA-617, for patients with metastatic castration-resistant prostate cancer (mCRPC) who test positive for the prostate-specific membrane antigen (PSMA) with an FDA-approved imaging diagnostic agent. Eligible patients must also have already tried an androgen receptor inhibitor and taxane-based chemotherapy.

The global leukemia cancer market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period. Increasing investments in the healthcare sector and the rising development of new drugs and therapeutics will drive the market in the forecast period. According to WHO, globally leukemia cancer is considered to be the most common blood cancer. Thus, to treat and cure rising incidences of cancer across the globe, drug manufacturers and market players are conducting several R&D activities. 

The global nuclear turbine generator market is anticipated to grow at a considerable CAGR of 3.0% during the forecast period (2022-2028). The speeding up in the adoption of nuclear turbine generators is one of the prime factors affecting and driving the market. Nuclear turbine generators are considered to be reliable, and safe, along with a clean source of energy when compared to conventional energy resources. Additionally, these generators are also considered to be cost-effective, one of the low-carbon energy sources supporting fulfilling the energy gap and it is also becoming necessary in order to respond in an effective manner to changes in climate and also to greenhouse gas emissions. T

The global hospital information system market is anticipated to grow at a considerable CAGR of 8.3% during the forecast period. The various new launches by players and investments by governments in the hospital information system market are propelling the growth of the market. For instance, in November 2021, Philips announced its new and enhanced vendor-neutral radiology workflow solutions and scalable smart connected imaging systems at RSNA 2021. The smart connected systems improve access to data and support advanced analytics and reporting for all aspects of the radiology service, from patient management and acquisition to interpretation and referral management.

The global HCFC refrigerant market is anticipated to grow at a considerable CAGR of 4.1% during the forecast period. The various key development and launches by players across the globe are surging the market growth over the forecast period. For instance, in April 2021, Honeywell announced that global natural and organic foods retailer Whole Foods Market has adopted its Solstice N40 (R-448A) lower global-warming-potential (GWP) refrigerant in its stores across the United States as it seeks to reduce refrigerant emissions under the U.S. Environmental Protection Agency's GreenChill program.

The global fertilizers market is anticipated to grow at a significant CAGR of 3% during the forecast period. The major factor driving the growth of the global fertilizers market during the forecast period is the decreasing per capita arable land across the globe. According to the FAO 'The Resource Outlook to 2050', more than 1.50 billion hectares of the world’s land surface, or about 12% is used for crop production. Additionally, the per capita arable land area will decline to 0.18 ha by 2050 globally as compared to 0.15 ha in developing countries and 0.42 ha in developed countries.

The global anti-aging market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period. An increase in concerns regarding the potential harm caused by pollution on the skin is further pushing manufacturers to grow their product lines. The various launches by key players across the regions are supporting the growth of the market over the forecast period. For instance, in October 2021, Ellen DeGeneres launched the ‘age-positive’ skincare brand. The line-up will cater to all types of skin irrespective of gender, race, and age. According to the website, “each product is uniquely developed using globally sourced, curated ingredients to target your primary skin concerns. 

The global electrophoresis market is anticipated to grow at a significant CAGR of 6.0% during the forecast period. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, in September 2021, BioPhase 8800, a new capillary electrophoresis technology from Sciex, has been released for improved biological characterization in the development of biopharmaceutical medicines.